PMID- 21854819 OWN - NLM STAT- MEDLINE DCOM- 20130129 LR - 20211203 IS - 1872-9754 (Electronic) IS - 0197-0186 (Linking) VI - 59 IP - 6 DP - 2011 Nov TI - Insulin-induced neurite-like process outgrowth: acceleration of tau protein synthesis via a phosphoinositide 3-kinase~mammalian target of rapamycin pathway. PG - 880-8 LID - 10.1016/j.neuint.2011.08.002 [doi] AB - Both insulin and tau, promoting neuronal differentiation (neurite outgrowth, neuronal polarity, and myelination) and cell survival, are associated with neurodegenerative disease (e.g., Alzheimer's disease). The aim of this study was to explore relation between insulin-induced activation of insulin signal and expression of tau protein on neurite-like process outgrowth in adrenal chromaffin cells. Primary cultured bovine adrenal chromaffin cells were incubated with insulin to determine whether stimulant of insulin signal could affect tau expression and neurite-like process outgrowth. Chronic treatment with insulin (⩾6h) led neurite-like process outgrowth as well as increased tau protein level by approximately 99% in a concentration (EC(50) 5.5nM)- and time-dependent manner, without changing Ser(396)-phosphorylated tau level. The insulin-induced increase of tau protein level was abolished by LY294002 [an inhibitor of phosphoinositide 3-kinase (PI3K)] and rapamycin [an inhibitor of mammalian target of rapamycin (mTOR)], but not by PD98059 and U0126 [two inhibitors of mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK)]. Additionally, insulin-induced increase of tau was blocked by cyclohexamide (an inhibitor of protein synthesis), but not by actinomycin D (an inhibitor of gene transcription). Pulse-label followed by polyacrylamide gel electrophoresis revealed that insulin accelerated tau protein synthesis rate (t(1/2)) from 2.6 to 1.9h. Insulin did not change tau mRNA level. Taken together, these results suggest that insulin-induced activation of PI3K approximately mTOR pathway up-regulated tau protein via acceleration of protein synthesis, on which insulin promoted neurite-like process outgrowth. CI - Copyright A(c) 2011 Elsevier B.V. All rights reserved. FAU - Nemoto, Takayuki AU - Nemoto T AD - Department of Pharmacology, Miyazaki Medical College, University of Miyazaki, Miyazaki, Japan. tnemoto@fc.miyazaki-u.ac.jp FAU - Yanagita, Toshihiko AU - Yanagita T FAU - Satoh, Shinya AU - Satoh S FAU - Maruta, Toyoaki AU - Maruta T FAU - Kanai, Tasuku AU - Kanai T FAU - Murakami, Manabu AU - Murakami M FAU - Wada, Akihiko AU - Wada A LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110809 PL - England TA - Neurochem Int JT - Neurochemistry international JID - 8006959 RN - 0 (Insulin) RN - 0 (tau Proteins) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Animals MH - Cattle MH - *Cell Enlargement/drug effects MH - Insulin/*pharmacology MH - Neural Pathways/drug effects/enzymology/physiology MH - Neurites/drug effects/enzymology/*physiology MH - Neurogenesis/drug effects/*physiology MH - Phosphatidylinositol 3-Kinases/*physiology MH - Primary Cell Culture MH - TOR Serine-Threonine Kinases/antagonists & inhibitors/genetics/*physiology MH - Up-Regulation/drug effects/*physiology MH - tau Proteins/*biosynthesis/metabolism EDAT- 2011/08/23 06:00 MHDA- 2013/01/30 06:00 CRDT- 2011/08/23 06:00 PHST- 2011/04/15 00:00 [received] PHST- 2011/07/28 00:00 [revised] PHST- 2011/08/01 00:00 [accepted] PHST- 2011/08/23 06:00 [entrez] PHST- 2011/08/23 06:00 [pubmed] PHST- 2013/01/30 06:00 [medline] AID - S0197-0186(11)00272-5 [pii] AID - 10.1016/j.neuint.2011.08.002 [doi] PST - ppublish SO - Neurochem Int. 2011 Nov;59(6):880-8. doi: 10.1016/j.neuint.2011.08.002. Epub 2011 Aug 9.